When a political crisis led to restrictions on spending on Madagascar’s public sector, the USAID-funded MAHEFA project innovated news ways and forged new partnerships to improve health outcomes at the community level.
In developing countries, many newborns pass away because they are exposed to germs and pathogens that cause infection. In fact, about a quarter of all newborn deaths are due to infections. However, a new medicine called chlorhexidine (CHX) has been proven very effective in preventing infection, also called newborn sepsis. Last week, a group of practitioners gathered in Washington, D.C. to discuss countries’ progress in introducing and scaling up the use of CHX, and the way forward. I was honored to be part of this group.